Ulta Beauty (ULTA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Ulta Beauty (ULTA) recently closed down 1.04%, underperforming broader market indices, despite an 11% gain over the past month. Ahead of its upcoming earnings report, analysts anticipate a year-over-year decline in both quarterly (8.11%) and annual (7.58%) EPS, though revenue is projected to rise modestly. ULTA currently trades at a Forward P/E of 22.17, a premium to its industry's 15.27, and holds a Zacks Rank #3 (Hold), with recent slight upward revisions to consensus EPS estimates.

Analysis

Ulta Beauty (ULTA) presents a mixed financial picture ahead of its upcoming earnings release. Despite a recent single-day stock decline of 1.04% that underperformed the broader market, the shares have logged a strong 11% gain over the past month, significantly outpacing both the S&P 500 and its retail sector. However, this recent momentum contrasts with consensus analyst expectations for the upcoming quarter, which project a year-over-year earnings per share (EPS) decline of 8.11% to $4.87, alongside a modest revenue increase of 1.7% to $2.6 billion. This suggests significant margin pressure, a trend that is also reflected in the full-year forecast of a 7.58% EPS contraction on 3.04% revenue growth. Valuation appears stretched, with a Forward P/E of 22.17 standing at a premium to its industry's average of 15.27, and a high PEG ratio of 3.14. While the consensus EPS estimate has seen a minor upward revision of 0.15% in the last 30 days, the company's neutral Zacks Rank #3 (Hold) and its position within a poorly ranked industry (bottom 22%) indicate a cautious outlook.

Key Decisions for Investors

• Given the high valuation, evidenced by a Forward P/E of 22.17 and a PEG ratio of 3.14, investors should be cautious as the current stock price may not fully reflect the anticipated 8.11% year-over-year decline in quarterly earnings.
• The upcoming earnings report is a critical catalyst; focus should be on management's commentary regarding margin pressures and the outlook for profitability, as the projected slow revenue growth is currently insufficient to offset contracting earnings.
• Considering the stock's recent 11% run-up against a backdrop of negative earnings forecasts and a weak industry rank, it may be prudent to adopt a neutral stance, aligning with the Zacks #3 (Hold) rating, until the company provides clear evidence of a path back to earnings growth.